Editoria e Media
Visiongain publishes Nasal Drug Delivery Technology Market Forecast 2020-2030 report
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 185-page report you will receive 54 charts– all unavailable elsewhere.
The 185-page Visiongain report provides clear detailed insight into the Global Nasal Drug Delivery Technology Market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
– Dosage Form: Nasal Sprays, Nasal Drops & Liquids, Nasal Gels, Nasal Powders
– Nasal Sprays: Non-pressurized Containers and Pressurized Containers
– Nasal Unidose Devices
– Nasal Bi Dose Devices
– Nasal Multi Dose Devices
– Asthma
– Allergic and Non-Allergic Rhinitis
– Nasal Congestion
– Hospitals
– Ambulatory Surgery Center
– Specialty Clinics
– Vaccination Centers
– United States
– Canada
– Brazil
– Mexico
– Rest of Latin America
– Germany
– UK
– Italy
– France
– Spain
– Nordic
– Benelux
– Rest of Western Europe
– Russia
– Poland
– Rest of Eastern Europe
– Japan
– China
– India
– Australia & New Zealand
– ASEAN
– Rest of Asia-Pacific
– GCC Countries
– South Africa
– North Africa
– Rest of MEA
– 3M Company
– Becton, Dickinson and Company
– GlaxoSmithKline plc
– Johnson & Johnson
– Merck & Co., Inc.
– Pfizer Inc.
– Teleflex Incorporated
– Naveh Pharma Ltd.
– OptiNose US, Inc.
– Pendopharm
– AptarGroup, Inc.
• This report provides qualitative analysis of the Global Nasal Drug Delivery Technology market. This report discusses the Porter's Five Forces Analysis, as well as the Drivers and Challenges of this market.
Visiongain's study is intended for anyone requiring commercial analyses for the Global Digital Wound Care Management market. You find data, trends and predictions.
3M Company
Allergy, Asthma and Clinical Immunology
American Academy of Allergy Asthma and Immunology
American Hospital of Paris
American Thoracic Society
AptarGroup, Inc.
Asthma and Allergy Foundation of America
AstraZeneca
Becton, Dickinson and Company
BREATH
Centers for Disease Control and Prevention
Currax Pharmaceuticals LLC
Eli Lilly and Company
European Academy of Allergy and Clinical Immunology (EAACI
Food and Drug Administration
GlaxoSmithKline plc
International Medical Device Regulators Forum (IMDRF)
International Severe Asthma Forum (ISAF
International Study of Asthma and Allergies in Childhood (ISAAC)
International Study of Asthma and Allergies in Childhood (ISAAC)
Johnson & Johnson
Merck & Co., Inc.
Ministry of Health, Labor, and Welfare (MHLW)
National Health Insurance (NHI)
Naveh Pharma Ltd.
Nemera
Neurelis, Inc.
Nordic Severe Asthma Network (NSAN)
OptiNose US, Inc.
Organisation for Economic Cooperation and Development
Pendopharm
Pfizer Inc.
Pharmaceutical Services Negotiating Committee
Pharmaceuticals and Medical Device Agency (PDMA)
Phronesis
Sanofi-aventis
Spanish National Guideline for the Management of Asthma
Teleflex Incorporated
UCB
Upsher-Smith Laboratories
World Allergy Organization Journal
World Health Organization
Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg